ATC code J05 - PDFSEARCH.IO - Document Search Engine

ATC code J05
Results: 13

#	Item
1	STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY Add to Reading List Source URL: health.tn.gov Language: English - Date: 2015-03-19 15:53:21 Fixed dose combination Gilead Sciences Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor ATC code J05 Emtricitabine Fixed-dose combination Chemistry Organic chemistry Pharmacology
2	STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY Add to Reading List Source URL: tn.gov Language: English - Date: 2015-03-19 08:38:15 Gilead Sciences Pharmacology Non-nucleoside reverse transcriptase inhibitors Organofluorides Bristol-Myers Squibb Reverse-transcriptase inhibitor ATC code J05 Emtricitabine Tenofovir Chemistry Organic chemistry Fixed dose combination
3	STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY Add to Reading List Source URL: health.state.tn.us Language: English - Date: 2015-03-19 15:53:21 Fixed dose combination Gilead Sciences Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor ATC code J05 Emtricitabine Fixed-dose combination Chemistry Organic chemistry Pharmacology
4	HIV/AIDS Expression of Interest EOI Add to Reading List Source URL: apps.who.int Language: English - Date: 2008-05-28 07:41:36 Organofluorides Bristol-Myers Squibb Non-nucleoside reverse transcriptase inhibitors Purines Fixed-dose combination Antiretroviral drug ATC code J05 Lamivudine Reverse-transcriptase inhibitor Chemistry Organic chemistry Cyclopropanes
5	Oklahoma HDAP Formulary effective[removed]FY 2014 Oklahoma HIV Drug Assistance Program Drug Formulary Brand Generic Aptivus Add to Reading List Source URL: www.ok.gov Language: English - Date: 2014-09-15 15:15:59 Organic chemistry Pharmacology Organofluorides Cyclopropanes Non-nucleoside reverse transcriptase inhibitors ATC code J05 Tenofovir Emtricitabine Abacavir Fixed dose combination Gilead Sciences Chemistry
6	Kentucky AIDS Drug Assistance Program Formulary Add to Reading List Source URL: www.chfs.ky.gov Language: English - Date: 2014-11-20 04:23:49 Gilead Sciences Pharmacology Non-nucleoside reverse transcriptase inhibitors Organofluorides Bristol-Myers Squibb Reverse-transcriptase inhibitor Emtricitabine ATC code J05 Antiretroviral drug Chemistry Organic chemistry Fixed dose combination
7	Microsoft Word - anticonvulsant-int Add to Reading List Source URL: www.hivclinic.ca Language: English - Date: 2014-09-19 13:57:23 Efavirenz Darunavir ATC code J05 Lopinavir/ritonavir Etravirine Tenofovir/emtricitabine Antiretroviral drug Atazanavir Tipranavir Chemistry Organic chemistry Protease inhibitors
8	INNTI PI S NRTI C OMBINATIONS Dietary Add to Reading List Source URL: www.hivmedicationguide.com Language: English - Date: 2013-06-10 11:00:25 Fixed dose combination Organofluorides Non-nucleoside reverse transcriptase inhibitors Carbamates ATC code J05 Darunavir Antiretroviral drug Reverse-transcriptase inhibitor Efavirenz Chemistry Organic chemistry Protease inhibitors
9	Kentucky AIDS Drug Assistance Program Formulary Add to Reading List Source URL: chfs.ky.gov Language: English - Date: 2014-09-09 08:48:52 Gilead Sciences Pharmacology Non-nucleoside reverse transcriptase inhibitors Organofluorides Bristol-Myers Squibb Reverse-transcriptase inhibitor Emtricitabine ATC code J05 Antiretroviral drug Chemistry Organic chemistry Fixed dose combination
10	STATE OF TENNESSEE DEPARTMENT OF HEALTH Ryan White Part B Program HIV DRUG ASSISTANCE PROGRAM (HDAP) FORMULARY Add to Reading List Source URL: health.state.tn.us Language: English - Date: 2013-01-31 14:25:12 Fixed dose combination Gilead Sciences Organofluorides Non-nucleoside reverse transcriptase inhibitors Bristol-Myers Squibb Reverse-transcriptase inhibitor Emtricitabine ATC code J05 Tenofovir Chemistry Organic chemistry Pharmacology

UPDATE